Pyxis Oncology, Inc. — All Filings
318 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
144
144/A
3
4
424B2
424B3
424B4
425
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
POS AM
PRE 14A
S-1
S-1/A
S-1MEF
S-3
S-4
S-4/A
S-8
S-8 POS
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 8-K | 8-K | 0000950170-25-040767 | Mar 18, 2025 | — |
| 10-K | 10-K | 0000950170-25-040771 | Mar 18, 2025 | Dec 31, 2024 |
| S-8 | S-8 | 0000950170-25-041315 | Mar 18, 2025 | — |
| 8-K | 8-K | 0000950170-25-027330 | Feb 26, 2025 | — |
| SCHEDULE 13G/A | — | 0001172661-25-000884 | Feb 14, 2025 | — |
| SCHEDULE 13G/A | — | 0001104659-25-014027 | Feb 14, 2025 | — |
| 8-K | 8-K | 0000950170-25-012846 | Feb 4, 2025 | — |
| SCHEDULE 13G | — | 0002012383-25-000665 | Feb 4, 2025 | — |
| 4 | 4 | 0000950170-24-139608 | Dec 23, 2024 | — |
| 4 | 4 | 0000950170-24-139616 | Dec 23, 2024 | — |
| 4 | 4 | 0000950170-24-139598 | Dec 23, 2024 | — |
| SCHEDULE 13D/A | — | 0000950170-24-139789 | Dec 23, 2024 | — |
| 8-K | 8-K | 0000950170-24-138563 | Dec 19, 2024 | — |
| SCHEDULE 13G | — | 0001104659-24-128889 | Dec 16, 2024 | — |
| 4 | 4 | 0000950170-24-131606 | Nov 27, 2024 | Nov 26, 2024 |
| 8-K | 8-K | 0000950170-24-129238 | Nov 20, 2024 | — |
| 8-K | 8-K | 0000950170-24-124581 | Nov 12, 2024 | — |
| 10-Q | 10-Q | 0000950170-24-124602 | Nov 12, 2024 | Sep 30, 2024 |
| SC 13G/A | LAURION CAPITAL MANAGEMENT LP | 0001085146-24-005529 | Nov 12, 2024 | — |
| S-8 | S-8 | 0000950170-24-125555 | Nov 12, 2024 | — |
| SC 13G/A | SC 13G/A | 0001104659-24-114823 | Nov 6, 2024 | — |
| 8-K | 8-K | 0000950170-24-116698 | Oct 23, 2024 | — |
| DEF 14A | DEF 14A | 0000950170-24-109337 | Sep 25, 2024 | — |
| PRE 14A | PRE 14A | 0000950170-24-106381 | Sep 13, 2024 | — |
| 8-K | 8-K | 0000950170-24-097054 | Aug 14, 2024 | — |
| 10-Q | 10-Q | 0000950170-24-097073 | Aug 14, 2024 | Jun 30, 2024 |
| 8-K | 8-K | 0000950170-24-072467 | Jun 12, 2024 | Jun 11, 2024 |
| 4 | 4 | 0000950170-24-071438 | Jun 10, 2024 | — |
| 8-K | 8-K | 0001193125-24-157911 | Jun 10, 2024 | — |
| 3 | 3 | 0000950170-24-071435 | Jun 10, 2024 | — |
| 4 | 4 | 0000950170-24-070833 | Jun 7, 2024 | — |
| 10-Q | 10-Q | 0000950170-24-059099 | May 14, 2024 | Mar 31, 2024 |
| 8-K | 8-K | 0000950170-24-059093 | May 14, 2024 | — |
| DEF 14A | DEF 14A | 0000950170-24-049154 | Apr 26, 2024 | Jun 11, 2024 |
| DEFA14A | DEFA14A | 0000950170-24-049161 | Apr 26, 2024 | — |
| ARS | ARS | 0000950170-24-049163 | Apr 26, 2024 | Dec 31, 2023 |
| 424B2 | FORM 424B2 | 0001437749-24-010967 | Apr 4, 2024 | — |
| SC 13D/A | SC 13D/A | 0000950170-24-041264 | Apr 3, 2024 | — |
| EFFECT | — | 9999999995-24-000851 | Apr 3, 2024 | — |
| CORRESP | — | 0000950170-24-039387 | Apr 1, 2024 | — |
| UPLOAD | — | 0000000000-24-003389 | Mar 29, 2024 | — |
| 4 | 4 | 0000950170-24-038098 | Mar 28, 2024 | Mar 26, 2024 |
| 4 | 4 | 0000950170-24-038097 | Mar 28, 2024 | Mar 26, 2024 |
| 4 | 4 | 0000950170-24-038099 | Mar 28, 2024 | Mar 26, 2024 |
| 4 | 4 | 0000950170-24-038108 | Mar 28, 2024 | Mar 26, 2024 |
| 4 | 4 | 0000950170-24-038102 | Mar 28, 2024 | Mar 26, 2024 |
| 4 | 4 | 0000950170-24-038103 | Mar 28, 2024 | Mar 26, 2024 |
| 4 | 4 | 0000950170-24-038105 | Mar 28, 2024 | Mar 26, 2024 |
| 4 | 4 | 0000950170-24-038104 | Mar 28, 2024 | Mar 26, 2024 |
| 4 | 4 | 0000950170-24-038106 | Mar 28, 2024 | Mar 26, 2024 |